TWEAK antibody (N-Term)
Quick Overview for TWEAK antibody (N-Term) (ABIN926993)
Target
See all TWEAK (TNFSF12) AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- N-Term
-
Cross-Reactivity
- Mouse (Murine), Dog (Canine)
-
Purification
- Purified
-
Immunogen
- TNFSF12 antibody was raised in rabbit using the N terminal of TNFSF12 as the immunogen
-
-
-
-
Application Notes
-
WB: 0.2-1 µg/mL
Optimal conditions should be determined by the investigator. -
Comment
-
TNFSF12 Blocking Peptide, , is also available for use as a blocking control in assays to test for specificity of this TNFSF12 antibody
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Concentration
- Lot specific
-
Buffer
- Lyophilized powder. Add 50 µL of distilled water. Final antibody concentration is 1 mg/mL in PBS buffer.
-
Handling Advice
- Avoid repeated freeze/thaw cycles.
-
Storage
- 4 °C/-20 °C
-
Storage Comment
- Store at 4 °C, following reconstitution, aliquot and store at -20 °C.
-
-
- TWEAK (TNFSF12) (Tumor Necrosis Factor (Ligand) Superfamily, Member 12 (TNFSF12))
-
Alternative Name
- TNFSF12
-
Background
- TNFSF12 is a cytokine that belongs to the tumor necrosis factor (TNF) ligand family. This protein is a ligand for the FN14/TWEAKR receptor. This cytokine has overlapping signaling functions with TNF, but displays a much wider tissue distribution. This cytokine can induce apoptosis via multiple pathways of cell death in a cell type-specific manner. This cytokine is also found to promote proliferation and migration of endothelial cells, and thus acts as a regulator of angiogenesis. Two alternatively spliced transcript variants of this gene encoding distinct isoforms have been reported. Synonyms: Polyclonal TNFSF12 antibody, Anti-TNFSF12 antibody, tumor necrosis factor, ligand superfamily, member 12 antibody.
-
Pathways
- Apoptosis
Target
-